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Targeted perturbationsAlthoughmanymethods have beendeveloped for inference of biological networks, the validation of the resulting
models has largely remained an unsolved problem. Here we present a framework for quantitative assessment of
inferred gene interaction networks using knock-down data from cell line experiments. Using this frameworkwe
are able to show that network inference based on integration of prior knowledge derived from the biomedical
literaturewith genomic data signiﬁcantly improves the quality of inferred networks relative to other approaches.
Our results also suggest that cell line experiments can be used to quantitatively assess the quality of networks
inferred from tumor samples.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction/methods
We have increasingly come to recognize that cellular regulatory
processes are more complex than we had once imagined and that it is
generally not individual genes, but networks of interacting genes and
gene products, which collectively interact to deﬁne phenotypes and
the alterations that occur in the development of a disease [4]. The ﬁrst
application of network reconstruction to gene expression used data
from a yeast cell cycle experiment in which synchronized cells were
proﬁled over a carefully planned time-course [28]. Friedman and
colleagues analyzed these data in a Bayesian Network framework to
develop a predictive cell-cycle model [13]. Since this early work, there
have beenmanyothermethods developed tomodel networkswhile ad-
dressing the intrinsic complexity of high-throughput genomic data
(high feature-to-sample ratio and high level of noise) [22]. However,
few methods have been widely used and often fail to produce useful
network models, mainly because there are no gold standards on how
to build and validate large gene networks [12,34].
One challenge in developing network inference methods is valida-
tion of the resultingmodels.Most published network inferencemethods-Kains),
. This is an open access article underattempt to validate their models through comparison with biological
databases, calculating the proportion of interactions found both in the
inferred networks and those databases [2]. However, this assumes that
the network topologies are static and do not change between pheno-
types or in response to perturbations. Others have validated small
networkmodels using targeted biological experiments to assess interac-
tions between genes, but this is not feasible for a large number of genes
and new potential interactions. An alternate route based on simulated
interventional data was used in the NIPS2008 workshop on causality
validating inferred networks by trying to predict the results of interven-
tions [16], but this method is biased to those network inference models
most closely resembling the simulation model.
Here we propose a new validation framework that enables a quanti-
tative and unbiased assessment of the performance of an inferred
network model. This framework relies on generating independent,
single-gene knock-down experiments targeting a collection of genes
in a network or pathway of interest, and measuring gene expression
data before and after the knock-downs. With this data in hand, we
apply the following iterative leave-one-out cross-validation approach
to assess the performance of a given network inference method (Fig. 1):
1. Select a single gene knock-down, including all replicates, from the
collection as validation set.
2. From the remaining knock-down experiments, build a predictive
network model.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1. Validation algorithm using single-gene knock-down experiments in a leave-one-
out cross-validation scheme.
2 http://www.biocarta.com/pathﬁles/h.
330 C. Olsen et al. / Genomics 103 (2014) 329–3363. Use the validation set to assess the network's quality, focused on
connections local to the perturbation.
4. Repeat steps 1–3 until all perturbations have been tested in the
models and their local predictive power assessed.
This “dual use” of the data for model inference and validation allows
the computation of a performance score that quantitatively assesses the
inferred network's quality based on a comparison between the genes
that are empirically determined to be affected based on the validation
data set and those genes inferred to be affected based on the models.
Since this validation framework is not tied to a speciﬁc network
inference method, it can be used to assess the relative performance of
different network inference methods. As a test of the approach, we
applied it to two methods that infer directed (causal) interaction net-
work from gene expression data: GeneNet [27] and predictionet [17].
GeneNet computes full partial correlations and then orders the genes
based on partial variances to identify directed acyclic causal networks.
This approach improves on Bayesian network inference methods as it
allows inference of large interaction networks containing hundreds of
genes. However, its current implementation (version 1.2.5) does not in-
tegrate prior knowledge about likely network structure captured in
published biomedical literature and pathway databases [9,14,18,32].
Bayesian networks are inferred from different sources of information
in [19,29,32] but to the best of our knowledge there is no such method
publicly available in R.
The use of prior network structures is at the heart of predictionet,
which builds on reported gene–gene interactions cataloged in the
Predictive Networks (PN), web application [17]. predictionet infers an
undirected network using mRMR (minimum Redundancy–Maximum
Relevance; [8,26]) feature selection and then orients the edges in this
network using the interaction information [25]. In both steps, prior
information can be used to adjust the respective rankings based on
the conﬁdence in the interactions, as further described in Section 1.1
of the Supplementary Information.
Here we will describe the application of our validation framework,
which combines knock-down experiments and network inference, to
quantitatively assess inference methods for large gene interactionnetworks.Wewill show that the integration of priors with gene expres-
sion data yielded networks best at predicting the genes affected by a
targeted perturbation.
2. Results
In this section we will present our validation framework and the
combination of targeted perturbations and network inference methods
it relies on. The data and the main parameters used in our framework
will be described in detail.
2.1. Targeted perturbations
One of the best approaches to test the quality of a network model is
to quantify how well it can predict the system's response to perturba-
tions. As a demonstration, we use a well-studied model system — the
RAS signaling pathway in colorectal cancer. We performed RNAi-
mediated gene knock-down experiments in two colorectal cancer cell
lines, SW480 and SW620 [20], targeting eight key genes in the RAS
pathway: CDK5, HRAS, MAP2K1, MAP2K2, MAPK1, MAPK3, NGFR and
RAF2. The experiments were done in six biological replicates of each
knockdown and controls in both cell lines. From each sample, we pro-
ﬁled gene expression (Supplementary File 1) using the Affymetrix
GeneChip HGU133PLUS2 platform. CEL ﬁles were normalized using
frma [24]. We used the jetset package to select a unique probeset for
each of the 19,218 unique gene symbols represented on the arrays; fur-
ther annotations were obtained using biomaRt [11]. The raw and nor-
malized data are available from the NCBI Gene Expression Omnibus
(GEO) repository [5] with accession numberGSE53091. Amore detailed
description of the knock-down experiments is available in Section 1.6 in
Supplementary Information.
Although our experimental perturbations were limited to eight
genes, the goal was to infer a larger network. Consequently, we needed
to identify a broader set of genes linked to the RAS pathway. We com-
pared gene expression proﬁles of quiescent cell lines over-expressing
RAS [6]. These data were generated using the Affymetrix GeneChip
HG-U133PLUS2 and normalized using MAS5 [1] (GEO accession
number: GSE3151). We used the Wilcoxon Rank Sum test to compare
the ten control cell lines with the ten cell lines over-expressing RAS
and selected the most differentially expressed genes (false discovery
rate FDR b10% and fold change ≥4) between groups; this identiﬁed
332 RAS-associated genes including HRAS itself. The unique set of 339
RAS-associated genes and our knock-down genes is listed together
with their corresponding statistics in Supplementary File 2.
With the gene expression data from the eight knock-down experi-
ments, we used the validation framework illustrated in Fig. 2(a). Each
knock-down was considered separately during the validation process.
In a ﬁrst step this entails the separation of the samples into those not
related to the knock-down under consideration (the training samples)
and the samples related to it (the validation samples). The validation
samples are then analyzed to identify the list of RAS-associated genes
signiﬁcantly affected by the target knock-down. To compare the expres-
sion of genes in control versus knock-down experiments we used the
Wilcoxon Rank Sum test with a FDR b10%. The lists of affected genes
and their annotations are reported in Table 1 and Supplementary File
3, respectively.
2.2. Network inference methods
Using the training samples (Fig. 2(a)) we then proceed to the infer-
ence of a network using either GeneNet or predictionet with different
weights on the priors (prior weight w ∈ {0, 0.25, 0.5, 0.75, 0.95, 1};
see Supplementary Information Sections 1.1 and 1.2 for details of the
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Fig. 2. In Fig. 2(a) a gene interaction network is inferred at each fold of the cross-validation whereas in Fig. 2(b) a single network is inferred from all the tumors in the data set. In both
settings we used the knock-downs (KD) of n= 8 key genes of the RAS pathway performed in colorectal cancer cell lines in order to quantitatively assess the network's quality.
331C. Olsen et al. / Genomics 103 (2014) 329–336inference algorithm and the parameter choices, respectively). To deﬁne
these priors we used the Predictive Networks (PN) web-application to
identify gene–gene interactions reported in the biomedical literature
and in structured biological databases [17] for this collection of genes.
The PN database was generated, in part, from PubMed abstracts and
full-text papers using a text mining method in which each interaction
is represented as a triplet [Subject, Predicate, Object] such as [PGC, is
inhibited by, SIRT1] or [CCNT1, regulates, PGC]. While the Subjects and
Objects represent genes, the Predicates capture the interactions between
these genes and include terms like ‘regulates’ or ‘is inhibited by’ that
describe directional interactions, here Subject→ Object or Subject←
Object, respectively. PN contains 81,022 interactions from PubMed
documents and 1,323,776 interactions from the Human Functional
Interaction [33] and the Pathways Common [7] databases (both retrieved
on 2012-11-16).
Among the 339 RAS-associated genes, 325 are present in the PN
database with a total of 37,212 interactions of which 602 occurred be-
tween pairs of RAS-associated genes (Supplementary File 4). Each inter-
action was characterized by an evidence score represented as the
difference between the number of positive evidence citations and the
number of negative evidence represented by a predicate such as ‘doesTable 1
Number of genes signiﬁcantly affected by KD (out of 339 genes) based on gene expression
data with FDR b10%.
KD
CDK5 HRAS MAP2K1 MAP2K2
Number of affected genes
73 122 33 38
MAPK1 MAPK3 NGFR RAF1
117 59 99 61not regulate’. More details on how the priors are used in predictionet
are available in Section 1.1 in Supplementary Information.2.3. Inferred networks
Next, we used the genomic data and priors to infer a gene interaction
network for each knock-down (CDK5, HRAS, MAP2K1, MAP2K2,
MAPK1, MAPK3, NGFR and RAF1) and each network inference methods
(GeneNet and predictionetwith increasingpriorweights). As anexample,
we will describe the network inferred for the HRAS knock-down using
predictionet with prior weight w = 0.5 (Fig. 3). Due to the size of the
network and the fact that we are primarily interested in the effect of
the targeted perturbation (knock-down of HRAS), we focus on that
part of the inferred network which models these effects, that are the
children and grand-children (referred to as CH2) of HRAS.
In theory, the genes inferred to be descendants of the knock-down
should correspond to the genes identiﬁed as signiﬁcantly affected in
the validation experiments. That is, when considering our validation
samples one can evaluate which genes exhibit a signiﬁcant change in
expression compared to the control samples; these affected genes
should ideally be present in the knock-down's childhood (CH).
We then testedwhether the inferred interactions (edges) in the net-
work were present in the prior (the blue edges) or not (gray edges).
This together with the knowledge of which genes were truly affected
by the knock-down allows us to identify possible new paths such as
HRAS-POLA2-CCDC94 that although not previously reported in the
literature, have empirical support in the perturbation data set.
Weﬁnd (Fig. 3) that truly affected genes are presentwithin the set of
children as well as with the grandchildren of HRAS; these nodes are
colored yellow. Although there are additional genes that are differen-
tially expressed in response to HRAS knockdown, for visualization
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Fig. 3. Children and grandchildren of HRAS (red node) inferred using predictionet, equal weight between training data and prior knowledge (prior weight w = 0.5). The yellow nodes
(genes) are the ones identiﬁed as signiﬁcantly affected by HRAS based on the validation samples. The remaining nodes, colored in blue, have been predicted as affected during network
inference while they were not identiﬁed as signiﬁcantly affected in the validation samples. Blue edges are known interactions (priors) while gray edges represent new interactions.
332 C. Olsen et al. / Genomics 103 (2014) 329–336purposes we focus on those that are predicted to be ﬁrst or second-
generation descendants of the knockdown target. To evaluate the
network's overall quality, we measured the ratio of those genes in the
KD's childhood that are affected by the perturbation relative to those
genes predicted to be in the childhood that are not affected. In the
following section we will use this idea to design a systematic quantita-
tive validation procedure by properly deﬁning true positives, false
positives and false negatives nodes.2.4. Systematic validation
Given an inferred network and a list of genes signiﬁcantly affected
by a speciﬁc knock-down, we can now classify the descendants of the
knock-down in the inferred network depending on their response to
the perturbation. If this is the case, each of these descendants is classi-
ﬁed as true positive (TP), as false positive (FP) if it was not affected by
the perturbation, and ﬁnally if we know that a gene was affected byTP FP FN
X2
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X5 X6
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Fig. 4. Given a set of genes affected by a knock-down gene KDi and a gene interaction net-
work, one can deﬁne nodes as true positives (TP), false positives (FP) and false negatives
(FN). In theory, all the affected genes should be inferred to be members of the knock-
down's childhood, denoted by CH. If they are found within CH, they are classiﬁed as true
positives (TP). All other genes in CH are classiﬁed as false positives (FP). Affected genes
that are not inferred to be in the knock-down's CH are classiﬁed as false negatives (FN).
This classiﬁcation of nodes into TP, FP and FN is then used to compute a quality score,
such as the F-score.the knock-down experiment but it is not inferred as a descendant in
the network, it is classiﬁed as false negative (FN), as illustrated in Fig. 4.
This classiﬁcation then allows us to compute, for the inferred
network, a quality measure such as the F-score
F ¼ 2TP
2TP þ FP þ FN ; F∈ 0;1½ ; ð1Þ
where F = 1 corresponds to the perfect classiﬁcation of the affected
genes and F = 0 to no correctly identiﬁed affected genes.
The question of which genes in the network qualify as ‘descendant’
is difﬁcult to answer and we chose to consider the knock-down's
children and its grandchildren, that is the childhood of distance two
(CH2). In our experiments, we see that considering only the direct
children (CH1) will include too few genes and it is not possible to
compute meaningful F-scores. On the other hand, considering larger
childhoods such as that of distance three (CH3) or even all descendants
usually leads to too many genes predicted as affected. Therefore, we
focus on analyzing results obtained for CH2 while reporting those for
CH1 and CH3 in Supplementary Information, Fig. 4.
Because increasing the size of the childhood almost automatically
leads to higher F-score values due to the greater weight given to true
positives versus false positives, one cannot solely rely on this quality
measure. Therefore, a second measure is needed that will penalize
networks with a greater number of edges. Our strategy is to generate
a large number n of random networks and compare their F-scores to
the F-score obtained with the inferred network to assess its signiﬁcance
using the following formula:
pval ¼
Xn
i¼1 1 Frandomi ≥ Finferred
 
n
: ð2Þ
The larger the number of edges is, the easier it will be to beat the
inferred network's performance with these random networks as the
variation between networks is reducingwith growing number of edges.
We generated random networks by mimicking the inference using
feature selection strategies as implemented by predictionet. Keeping
333C. Olsen et al. / Genomics 103 (2014) 329–336the number of edges and the maximum number of parents equal to
those of the inferred network, the random network generator adds a
uniformly distributed number of parents in [1, maxparents] to each
gene in the random network. This allows us to show that the feature
selection and arc orientation strategy implemented in predictionet
indeed performs statistically signiﬁcantly better than a randomedge ad-
dition procedure. Network performance is computed in terms of F-score
values associatedwith a knock-down's childhood and any networkwith
a p-value as deﬁned in Eq. (2) lower than 0.05 is considered to be signif-
icantly better than random networks.
2.4.1. Inferring networks with different prior weights for all knock-downs
With this combination of two complementary quantitative valida-
tion measures we can now evaluate the inferred networks, those
obtained using GeneNet with only genomic data and those obtained
using predictionetwith genomic data and priors for different weighing
schemes. We allowed the prior weights w to vary between 0 and 1,
the former corresponding to networks inferred from genomic data
only and the latter to networks inferred from prior knowledge
only: w ∈ {0, 0.25, 0.5, 0.75, 0.95, 1}.
To assure a fair comparison between GeneNet and the network
inferred from data only with predictionet and the associated random
network topologies, we constrained GeneNet networks to have the
same number of edges as those networks inferred using predictionet.
We chose to take the number of edges obtained with predictionet
using prior weight of 0.5 for two reasons. Firstly, although GeneNet is
not designed to natively integrate prior knowledge, we tested whether
combining data and prior using predictionetwill yield better results thanG
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Fig. 5. Bar plots reporting the performance of gene interaction networks, in cancer cell lines, in
predictionetwith priors only (priorweightw=1)and predictionetusing combinations of both d
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to be higher for networks with greater numbers of edges, therefore
choosing a prior weight which results in an advantageous number of
edges, such as 0.5, seems reasonable.
Using our validation framework (Fig. 2(a)), we analyzed our set of
colorectal cancer cell lines and computed F-scores of the inferred net-
works in cross-validation for each of the eight KDs (Fig. 5A).We ﬁrst in-
vestigated the performance of networks inferred from prior knowledge
only (prior weight w= 1). To the best of our knowledge, the informa-
tional value of priors retrieved from biomedical literature and struc-
tured biological databases has not yet been quantitatively assessed in
the context of gene network inference. Indisputable, these known inter-
actions are often the result of biological experiments that are valid in the
context in which they have been performed. However, this does not
necessarily mean that they carry information with respect to biological
data sets generated outside of this context. In our study we found that
networks inferred from priors only are informative as they yielded sig-
niﬁcant F-scores for all the knock-downs except NGFR (Fig. 5A and
Table 2). This is due to the fact that we found only few prior information
regarding the downstream effects of NGFR, with only one direct child
and no grandchild in the priors, which is not sufﬁcient to compute a
meaningful F-score.
To test whether combining prior knowledge with genomic data
leads to an improved inference of gene interaction networks, we com-
pared F-scores obtained for networks inferred from data only (GeneNet
and predictionet with prior weight w = 0), from priors only (prior
weight w = 1) and a combination of data and priors (prior weight
w ∈ [0, 1]). As can be seen in Fig. 5A, networks inferred fromGeneNet
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Table 2
Inference using knock-down data in cross-validation: #edges denote the number of edges in the inferred network; CH2 denotes the number of genes in the KD's childhood consisting of
children and grandchildren; TP and F-score denote the number of true positives and F-score for the childhood consisting of children and grandchildren.
CDK5 HRAS MAP2K1 MAP2K2
GeneNet
pndata
pnw0.25
pnw0.5
pnw0.75
pnw0.95
pnprior
MAPK1 MAPK3 NGFR RAF1
GeneNet
pndata
pnw0.25
pnw0.5
pnw0.75
pnw0.95
pnprior
#edges CH2 TP Fscore
#edges CH2 TP Fscore
#edges CH2 TP Fscore
#edges CH2 TP Fscore
#edges CH2 TP Fscore
#edges CH2 TP Fscore
#edges CH2 TP Fscore
#edges CH2 TP Fscore
1006 2 1 0.026667
586 16 6 0.13483
802 43 12 0.2069
1006 62 18 0.26667
1024 78 24 0.31788
1029 78 24 0.31788
313 49 13 0.21311
1017 0 0 0
607 6 4 0.065041
818 66 27 0.29508
1017 100 36 0.3318
1033 100 36 0.3318
1035 100 36 0.3318
313 58 22 0.25143
1058 0 0 0
661 16 7 0.10145
861 28 12 0.16
1058 37 17 0.21384
1077 37 17 0.21384
1080 37 17 0.21384
313 29 16 0.21192
1016 0 0 0
593 13 0 0
783 53 5 0.089286
1016 87 22 0.30137
1031 94 22 0.28758
1033 94 22 0.28758
313 48 11 0.20561
1044 0 0 0
637 0 0 0
831 34 5 0.14925
1044 46 5 0.12658
1062 46 5 0.12658
1066 46 5 0.12658
313 36 5 0.14493
1014 0 0 0
578 7 5 0.09434
787 18 9 0.15385
1014 10 6 0.11009
1027 10 6 0.11009
1031 10 6 0.11009
313 1 0 0
1025 3 1 0.04878
610 21 3 0.10169
811 49 9 0.2069
1025 61 11 0.22222
1043 61 11 0.22222
1048 61 11 0.22222
313 33 5 0.14085
1025 0 0 0
603 11 1 0.027778
792 26 5 0.11494
1025 58 13 0.21849
1044 59 13 0.21667
1049 59 13 0.21667
313 29 9 0.2
334 C. Olsen et al. / Genomics 103 (2014) 329–336combination of priors and genomic data yielded consistently higher
F-scores than networks inferred from genomic data alone (Wilcoxon
signed rank test p = 0.004 for prior weight w = 0.5). When com-
pared to networks inferred from priors only, we observe statistically
signiﬁcant improvement in the F-score for ﬁve out of eight KDs
(CDK5, MAP2K2, MAPK1, MAPK3 and NGFR; Wilcoxon signed rank
test p = 0.01 for prior weight w = 0.5). Moreover the networks in-
ferred from combined data sources are signiﬁcantly better than random
networks inmost cases, except for NGFR for which the prior knowledge
is limited (Fig. 5A).
We then assessed the beneﬁt of combining data sources by counting
how many true positives can only be found by combining priors and
genomic data, that is they are not present in the data only and/or priors
only networks (Fig. 4). In other words it does not sufﬁce to fuse the data
and prior-only networks to get these true positives. Fig. 5B represents
the portion of true positives that can be found in the networks inferred
from genomic data only, priors only or the combination of both.We ob-
serve in Fig. 5B that there is little overlap between true positives identi-
ﬁed in networks inferred from genomic data only or priors only,
suggesting that priors and genomic data provide very different informa-
tion regarding gene interactions. Moreover, we ﬁnd that a substantial
proportion of new true positives could have only been found by com-
bining data sources, highlighting the beneﬁt of combining priors and
data to infer networks (Fig. 5B, Table 2).
2.4.2. Extrapolate to tumor patient data
Having shown that the knock-down experiments enable quantita-
tive assessment of the quality of an inferred network, we apply our
validation framework to a large data set of 292 colorectal human tumors
(expO data set3). We infer gene interaction networks using the entire
data set as training set and used the knock-down experiments to assess
network quality as before (Fig. 2(b)). Such comparison between patient
samples and laboratory models is recognized as imperfect as colorectal
cell lines are not precise models for patient's tumors [15,23].
The networks inferred from colorectal tumor data were denser than
those inferred from cell lines (Supplementary Information, Table 1);
this is expected due to the larger sample size of the tumor data set
(~300 vs ~100 for the colorectal tumor and cell lines, respectively)
and its correspondingly greater diversity. Despite the difference in net-
work density the F-scores were not statistically signiﬁcantly different to3 https://expo.intgen.org/geo/.those found for the cell line knock-down experiments (Wilcoxon signed
rank test p ≥ 0.10, Fig. 6).
We found that GeneNet performed better on the tumor data than
on the KD data, possibly due to the larger sample size. However
GeneNet only provides signiﬁcant results for MAPK1 compared to
random networks (Fig. 6). On the contrary, networks inferred using
combination of genomic data and priors with predictionet yielded
signiﬁcant F-scores in most cases, except for NGFR which is consis-
tent with the cell line knock-down experiments. Again, combining
data with the prior knowledge improved F-scores for CDK5,
MAP2K1, MAP2K2, MAPK1, MAPK3 and RAF1. This is again consis-
tent with the cell line results.
Given that the networks inferred from colorectal cancer cell lines
and tumor data (Supplementary Files 5–8) yielded similar F-scores,
we compared their topologies to identify the edges inferred in both
data sets and those speciﬁc to either cell lines or tumors. For this,
because we do not use the test data for validation, we infer a single net-
work using the entire knock-down data set. This cell line network and
the tumor network shared on average 22% of edges depending on the
methods (4%, 5%, 20%, 31%, 33% and 33% for GeneNet, predictionetwith
priorweightw=0, 0.25, 0.5, 0.75 and 0.95, respectively; Supplementary
Information, Table 2). As expected, the proportion of common edges
increases with the prior weight; however the networks shared fewer
than one third of their edges, suggesting that either the gene interac-
tions present in cell lines and tumors signiﬁcantly differ from each
other or that the sample size in the cell line knockdown experiments
was not sufﬁcient to infer networks that are generalizable to other
data sets.
Moreover we observed that most of the common interactions
involve one of the eight KD genes (41%, p b 0.001 for predictionet
with prior weight w = 0.5), suggesting that more generalizable
networks could be inferred when performing targeting experi-
ments, which is supported by recent studies [3,30]. We illustrated
this result in Supplementary Information, Fig. 8 which represents
the gene interaction network surrounding HRAS, which shows
that most common interactions involve at least one of the KD
gene.3. Discussion
Inference of biological networks from genomic and other data has
the potential to provide insight into mechanisms driving complex phe-
notypes including diseases such as cancer. However, the validation of
large gene interaction networks remains a challenging task. The most
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Fig. 6. Bar plots reporting the performance of gene interaction networks, in patients' tumors, inferred genomic data only (GeneNet and predictionet (PN) with prior weight w = 0),
predictionetusing priors only (priorweightw=1) and predictionetusing a combination of both data sources (priorweightw= 0.25, 0.5, 0.75, 0.95). Each column reports the performance
of the network validated in each KD. Bars represent the F-scores of each network in each validation experiment; they are coloredwith respect to their signiﬁcance, that is in red and purple
when network's F-score is higher than 5% and 10% of random networks, respectively.
335C. Olsen et al. / Genomics 103 (2014) 329–336widely used validation approaches consist of comparing network edges
to ‘known’ gene–gene interactions derived from the literature or path-
way databases. However, such validation is in many ways limiting and
imperfect.
Firstly, it prevents the use of prior knowledge in network inference if
this is to be used subsequently for validation as it would lead to over-
ﬁtting and thus provide an overoptimistic performance evaluation for
the inferred networks. Secondly, it may be that most prior knowledge
are not speciﬁc to the biological conditions or phenotypes under inves-
tigation, which makes it difﬁcult to identify a set of standard references
of relevant interactions. Further, we and others have suggested that
prior knowledge could be used to improve network inference [9,18];
therefore we developed a new network inference approach, called
predictionet, to efﬁciently integrate priors, in the form of gene–gene
interactions extracted from biomedical literature and structured biologi-
cal databases [17].
The ﬁeld of network inference lacks quantitative, unbiased valida-
tion frameworks purely driven by data [10,21,31]. In this paper we
present a new validation framework using (I) experimental knock-
down data to compute the inferred network's performance (F-score)
and (II) to assess network's performance based on p-values computed
using random networks as null hypothesis to ensure statistical signiﬁ-
cance of the results. These two parts are complementary as only
relatively sparse networks are likely to be signiﬁcantly better than ran-
dom networks and networks with more interactions are more likely to
yield higher F-scores. Within this framework, we showed how difﬁcult
it is to infer networks solely based on genomic data both for GeneNet
and predictionet. Furthermore, we provided evidence for the quality of
prior knowledge retrieved through the Predictive Networks web-
application. Finally, we were able to show that combining genomic
data and prior networks lets us achieve higher F-scores than either of
the sources achieves by themselves, while at the same time inferring
networks that were also signiﬁcantly better than random networks.
When using patients' tumor data, we obtained comparable results, sug-
gesting that cell line experiments can be used for the validation of
patient data.
This study has some potential limitations. First, we targeted a small
set of eight key genes from the RAS signaling pathway but assessed
their effect on other genes from the entire genome. Second, these KDs
were performed for single genes, which do not allow us to assess the
effect of multiple simultaneous KDs. Third we performed the KD exper-
iments on two colorectal cancer cell lines; extension of our validation
framework to a larger number of cell lines and additional single and
multiple gene KDs is likely to improve our ability to infer robust geneinteraction networks. Lastly, we focused on a RAS signature of 339
genes to limit the computational time required to infer multiple
networks; we are working on parallelizing the predictionet package to
enable network inference from more genes, potentially the whole
genome.
In conclusion, we demonstrated that performance of gene interac-
tion networks inferred from high-throughput genomic data can be
quantitatively assessed and compared using targeted experiments.
Moreover we showed that priors, in the form of gene–gene interactions
extracted from biomedical literature and structured biological data-
bases using the Predictive Networks web-application, produce relevant
networks on their own and substantially improve networks' perfor-
mances when efﬁciently integrated in the inference process. Finally
we were able to use the gene perturbation data generated in cell lines
to assess the performance of networks inferred from patient tumor
samples, suggesting that our validation framework could be applied in
a translational research setting.
In this supplementary ﬁle we describe in more detail the network
inference approach implemented in predictionet and the knock-down
experiments. Furthermore we present additional results: F-scores for
KD and tumor data for different childhood sizes (CH1, CH2, CH3) and
the sources of the true positives for the networks inferred from KD
data for the three different childhood sizes. Then we present a compar-
ison of the KD's childhood (CH2) for each knocked down gene between
the network inferred from KD data and from the tumor patient data
expO. Finally, we provide additional tables with results of the inference
from the tumor data set, a comparison between networks from KD data
and expO with respect to the networks' edges and with respect to the
common genes in the respective childhood. Supplementary data associ-
atedwith this article can be found, in the online version, at http://dx.doi.
org/10.1016/j.ygeno.2014.03.004.Acknowledgments
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